Guidelines and Policies for HuBMAP Associate Membership
December 2, 2019
The NIH HuBMAP Program (https://commonfund.nih.gov/hubmap), funded by the NIH Common Fund, aims to catalyze development of a framework for mapping of the human body at high resolution to transform our understanding of tissue organization and function. Researchers funded as part of this program are developing novel technologies, resources, and data intended to accelerate research in this field.
The HUBMAP Program offers researchers not currently funded by HuBMAP the opportunity to apply to join the program as non-voting Associate Members. Associate Members are expected to contribute to the research goals of the Consortium by generating, sharing or analyzing data; jointly developing software or algorithms; developing mutually beneficial resources, protocols or reagents; or coordinating development of standards, formats or metadata.
Associate Members are also encouraged to actively engage in HuBMAP Consortium activities as non-voting members (i.e. participate in working groups as appropriate, attend the Annual Meeting etc.) and to abide by all policies approved by the Consortium (https://hubmapconsortium.org/policies/), including the Data Use Agreement, Data Sharing Policy, Publication Policy and any other pertinent NIH policies. Failure to abide by these rules and policies may result in suspension of membership. Prior to attending closed grantee meetings, Associate Members will be required to sign a conflict of interest certification. Any publication of data originating with HuBMAP by Associate Members should involve collaboration with HuBMAP membership, acknowledge HuBMAP as data source, not analyze non-public data without the written consent of the data generators and acknowledge the NIH Common Fund as funding source.
Investigators that wish to apply for Associate Member status should submit a letter of intent to Dena Procaccini (Dena.Procaccini@nih.gov) with a cc to the HIVE-IEC (firstname.lastname@example.org) that identifies who is involved in the collaboration, how long the collaboration is expected to be active, describes their planned contribution (e.g. datasets, analyses, reagents), and summarizes how the work will contribute to the mission of HuBMAP. The letter should also include a statement that indicates their willingness to abide by all relevant policies, as stated above. Letters will be reviewed initially by the Executive Committee and then brought to the HuBMAP Steering Committee for discussion and approval by the Steering Committee members and NIH staff. Applicants will be notified of the decision following this meeting; associate members and their institutions invited to join the Consortium will be asked to sign on to all relevant policies, including the Data Use Agreement, prior to any collaborations beginning. The EC will review and recommend renewal of Associate Member status periodically to ensure they are active and in good standing.
Associate membership does not directly or indirectly imply a commitment to funding by the NIH.
Return to Home.